Press Release

  • Grand News Network
  • November 6, 2023

eFFECTOR Therapeutics to Participate in Fireside Chat at 2023 Stifel Healthcare Conference

SOLANA BEACH, Calif. and REDWOOD CITY, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR), a leader in the development of selective translation regulator inhibitors ("STRIs") for the treatment of cancer, today announced that the Company will participate in a fireside chat discussion and host 1x1 meetings at the 2023 Stifel Healthcare Conference taking place November 14-15, 2023 in New York, NY.

Steve Worland, Ph.D., president and chief executive officer of eFFECTOR, will participate in a fireside chat discussion of the Company's clinical development pipeline and corporate strategy to be held on Wednesday, November 15 at 12:40 PM ET.

A live webcast of the event will be available on the "Events and Presentations" page of the Investors section of the Company's website with a replay available for 90 days following the event. For more information, please visit

About eFFECTOR Therapeutics


Full story available on

Disclaimer: The views, recommendations, and opinions expressed in this content belong solely to the third-party experts. This site was not involved in the writing and production of this article.

Disclaimer Press Release Banner

Cryptocurrency Rates

More to read